291 related articles for article (PubMed ID: 37882914)
1. Preclinical models of treatment-resistant depression: challenges and perspectives.
Kolasa M; Faron-Górecka A
Pharmacol Rep; 2023 Dec; 75(6):1326-1340. PubMed ID: 37882914
[TBL] [Abstract][Full Text] [Related]
2. Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression.
Willner P; Gruca P; Lason M; Tota-Glowczyk K; Litwa E; Niemczyk M; Papp M
Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):239-250. PubMed ID: 30204592
[TBL] [Abstract][Full Text] [Related]
3. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
[TBL] [Abstract][Full Text] [Related]
4. Models of Affective Illness: Chronic Mild Stress in the Rat.
Papp M; Willner P
Curr Protoc; 2023 Mar; 3(3):e712. PubMed ID: 36892313
[TBL] [Abstract][Full Text] [Related]
5. Perspectives for therapy of treatment-resistant depression.
Papp M; Cubala WJ; Swiecicki L; Newman-Tancredi A; Willner P
Br J Pharmacol; 2022 Sep; 179(17):4181-4200. PubMed ID: 34128229
[TBL] [Abstract][Full Text] [Related]
6. Overview of treatment-resistant depression.
Li CT
Prog Brain Res; 2023; 278():1-23. PubMed ID: 37414489
[TBL] [Abstract][Full Text] [Related]
7. Next generation antidepressants with novel mechanisms for treatment resistant depression.
Chen MH; Tu PC; Su TP
Prog Brain Res; 2023; 278():149-168. PubMed ID: 37414491
[TBL] [Abstract][Full Text] [Related]
8. The burden and the challenge of treatment-resistant depression.
Touloumis C
Psychiatriki; 2021 Dec; 32(Supplement I):11-14. PubMed ID: 34990376
[TBL] [Abstract][Full Text] [Related]
9. The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences.
Millard SJ; Weston-Green K; Newell KA
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109908. PubMed ID: 32145362
[TBL] [Abstract][Full Text] [Related]
10. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review.
Sukhram SD; Yilmaz G; Gu J
Oxid Med Cell Longev; 2022; 2022():1061274. PubMed ID: 36160713
[TBL] [Abstract][Full Text] [Related]
12. Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.
Brand SJ; Harvey BH
Acta Neuropsychiatr; 2017 Aug; 29(4):207-221. PubMed ID: 27692010
[TBL] [Abstract][Full Text] [Related]
13. Personal recovery associated with deep brain stimulation for treatment-resistant depression: A constructivist grounded theory study.
Raffin Bouchal DS; Ferguson AL; Green T; McAusland L; Kiss Z; Ramasubbu R
J Psychiatr Ment Health Nurs; 2023 Oct; 30(5):1005-1018. PubMed ID: 37002931
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression.
Bottemanne H; Morlaas O; Claret A; Sharot T; Fossati P; Schmidt L
JAMA Psychiatry; 2022 Nov; 79(11):1124-1132. PubMed ID: 36169969
[TBL] [Abstract][Full Text] [Related]
15. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
[TBL] [Abstract][Full Text] [Related]
16. Can Machine Learning help us in dealing with treatment resistant depression? A review.
Pigoni A; Delvecchio G; Madonna D; Bressi C; Soares J; Brambilla P
J Affect Disord; 2019 Dec; 259():21-26. PubMed ID: 31437696
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of New Approaches to Depression Treatment Using an Animal Model of Pharmacoresistant Depression.
Zvozilova A; Bukatova S; Koprdova R; Mach M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791304
[TBL] [Abstract][Full Text] [Related]
18. Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications.
Dandekar MP; Fenoy AJ; Carvalho AF; Soares JC; Quevedo J
Mol Psychiatry; 2018 May; 23(5):1094-1112. PubMed ID: 29483673
[TBL] [Abstract][Full Text] [Related]
19. Genomic Screening of Wistar and Wistar-Kyoto Rats Exposed to Chronic Mild Stress and Deep Brain Stimulation of Prefrontal Cortex.
Papp M; Gruca P; Faron-Górecka A; Kusmider M; Willner P
Neuroscience; 2019 Dec; 423():66-75. PubMed ID: 31705885
[TBL] [Abstract][Full Text] [Related]
20. AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar-Kyoto rats.
Papp M; Gruca P; Lason M; Litwa E; Solecki W; Willner P
J Psychopharmacol; 2020 Dec; 34(12):1418-1430. PubMed ID: 33200659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
